Correction
Published on 13 Apr 2023
Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1
in Cancer Molecular Targets and Therapeutics
- 1,267 views
Correction
Published on 13 Apr 2023
in Cancer Molecular Targets and Therapeutics
Correction
Published on 12 Apr 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 11 Apr 2023
in Cancer Molecular Targets and Therapeutics
Review
Published on 03 Apr 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 03 Apr 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 03 Apr 2023
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 30 Mar 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 28 Mar 2023
in Cancer Molecular Targets and Therapeutics
Review
Published on 28 Mar 2023
in Cancer Molecular Targets and Therapeutics
Systematic Review
Published on 27 Mar 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 27 Mar 2023
in Cancer Molecular Targets and Therapeutics
Review
Published on 27 Mar 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Mar 2023
in Cancer Molecular Targets and Therapeutics
Review
Published on 24 Mar 2023
in Cancer Molecular Targets and Therapeutics
Brief Research Report
Published on 23 Mar 2023
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 23 Mar 2023
in Cancer Molecular Targets and Therapeutics